Invention Grant
US08685651B2 Method for screening for an anti-CD4 antibody suitable for use in immunotherapy
有权
筛选适合用于免疫治疗的抗CD4抗体的方法
- Patent Title: Method for screening for an anti-CD4 antibody suitable for use in immunotherapy
- Patent Title (中): 筛选适合用于免疫治疗的抗CD4抗体的方法
-
Application No.: US12392556Application Date: 2009-02-25
-
Publication No.: US08685651B2Publication Date: 2014-04-01
- Inventor: John Wijdenes , Helmut Jonuleit
- Applicant: John Wijdenes , Helmut Jonuleit
- Applicant Address: DE Dreieich
- Assignee: Biotest AG
- Current Assignee: Biotest AG
- Current Assignee Address: DE Dreieich
- Agency: Shelly Guest Cermak Cermak Nakajima LLP
- Priority: EP03290725 20030321; EP03290942 20030416
- Main IPC: G01N33/53
- IPC: G01N33/53
Abstract:
A humanized antibody derived from mouse monoclonal anti-CD4 antibody B-F5 is able to activate CD25+CD4+ regulatory T cells and is useful for preparing immunosuppressive compositions.
Public/Granted literature
- US20090208497A1 HUMANIZED ANTI-CD4 ANTIBODY WITH IMMUNOSUPPRESSIVE PROPERTIES Public/Granted day:2009-08-20
Information query
IPC分类:
